pivekimab sunirine
immunogen
['cadenza', 'pivekimab', 'immunogen ', '$imgn']
$imgn immunogen presents updated findings from cadenza trial of pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm at eha 2023 congress 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities